Sort by
Refine Your Search
-
the instructions detailed on the participating university’s webpage . b) The EOI is assessed by the supervisory team and shortlisted applicants are interviewed. c) The supervisory team nominates a preferred
-
, including members specialising in biology, microfluidics, machine learning and clinical research from RMIT University and Leading Technology Group (LTG). LTG is an Australian group of medical research
-
sensing, to improve worker/operator safety. This project will focus on using density functional theory calculations and ab initio molecular dynamics simulations. The project is a collaboration with Dr
-
(or equivalent) in a relevant discipline (e.g., information science, sociology, digital humanities, computer science, information systems, media studies). Have strong social research (quantitative/qualitative
-
study), with a possible extension of six months. This amount is subject to indexation annually. International candidates in receipt of this scholarship are also awarded an RTP International Tuition Fee
-
Work with immunologists, bioinformaticians and clinical trials to better understand the effects and long-term complications of COVID-19 on the immune system, or the response to COVID-19 vaccines in
-
-based molecular biophysics project of medical significance, funded by the National Institutes of Health, USA. The Computational Biophysics Group develops advanced physical and chemical simulation
-
These models are technology platforms that facilitate drug discovery and fundamental research. Our research is funded by Australian Research Council. This project aims to develop bio-microfluidic
-
PhD Scholarship in ‘Using nanoparticles to enhance the immune response and improve vaccine efficacy’
to generate a strong immune response, capable of protecting against severe diseases such as cancer or malaria. The value of the Scholarship is equivalent to an RMIT full Scholarship This Scholarship will be
-
This is an exciting opportunity to examine how in this new pandemic world, healthcare as we know it will and must continue to innovate and adapt, leveraging digital health innovations to its full